2020
DOI: 10.1016/j.semerg.2019.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Déficit de glucosa-6-fosfato-deshidrogenasa (G6PD) en países occidentales. Revisión bibliográfica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Patel et al (1) concluded that apart from one trial which reported increased rates of hypernatremia, no other demonstrated increased adverse event rates when using IV vitamin C doses greater than 10 g per day. Glucose-6 phosphate dehydrogenase deficiency (G6PD) (2) is the most common human enzyme defect, and the vast majority of G6PD patients are, unless exposed to certain triggers, asymptomatic (2). Increased migration has clearly increased the number of asymptomatic G6PD patients in Western countries (2).…”
Section: To the Editormentioning
confidence: 99%
See 2 more Smart Citations
“…Patel et al (1) concluded that apart from one trial which reported increased rates of hypernatremia, no other demonstrated increased adverse event rates when using IV vitamin C doses greater than 10 g per day. Glucose-6 phosphate dehydrogenase deficiency (G6PD) (2) is the most common human enzyme defect, and the vast majority of G6PD patients are, unless exposed to certain triggers, asymptomatic (2). Increased migration has clearly increased the number of asymptomatic G6PD patients in Western countries (2).…”
Section: To the Editormentioning
confidence: 99%
“…Glucose-6 phosphate dehydrogenase deficiency (G6PD) (2) is the most common human enzyme defect, and the vast majority of G6PD patients are, unless exposed to certain triggers, asymptomatic (2). Increased migration has clearly increased the number of asymptomatic G6PD patients in Western countries (2). Administration of high-dose vitamin C, far above 6 g per day (as in the meta-analysis described by Patel et al [1]), will risk possible life-threatening methemoglobinemia in previously asymptomatic patients not screened for G6PD (2, 3).…”
Section: To the Editormentioning
confidence: 99%
See 1 more Smart Citation